Partnering with Hikma

Partnering is part of our strategy to  bring new and innovative products to patients in our regions.

We remain focused on building an increasingly diverse portfolio through investments in internal R&D, partnerships and strategic acquisitions.

Our broad geographic presence, strong manufacturing and commercial capabilities, deep knowledge of local markets and long-standing reputation makes us uniquely positioned to attract partners. This enables us to grow our portfolio and increase patients’ access to differentiated medicines across our markets, putting better health within reach, every day.

For all business development enquiries contact:

US and Canada:


Latest partnership news

All news stories
Decorative image.

Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...

Press Release, Business Development 12 February 2024
Related content

Explore more